文献速递肝病

真实世界证据支持HBeAg阳性慢性乙肝更早治疗,但不支持HBeAg阴性者

Real-world evidence supports earlier treatment in HBeAg-positive but not HBeAg-negative chronic hepatitis B virus infection
RSS 订阅 · Gut (BMJ)

本文结合2025年EASL慢性乙肝指南,解读Tang等基于中国大型多中心队列的真实世界数据,验证EASL风险分层框架:HBeAg阳性者尤其合并HCC危险因素时应更早干预,而HBeAg阴性低风险感染者预后良好、可暂不治疗。

要点

  • 2025年EASL指南扩大治疗范围,但仍按风险分层,未建议所有HBV DNA阳性者治疗。
  • HBeAg阴性感染者(原「非活动携带者」)不治疗通常预后良好。
  • HBeAg阳性者尤其存在HCC危险因素时,应提倡更早干预。

核心结论

  • 真实世界数据支持EASL框架:HBeAg阳性者更早治疗,HBeAg阴性者不主张普遍早期治疗。

研究设计与样本

  • Tang等开展的大型多中心中国队列真实世界分析,对2025年EASL指南框架进行验证。

主要发现

  • HBeAg阴性低水平感染(原文此处省略)者预后良好,支持可不治疗。
  • HBeAg阳性者尤其合并HCC危险因素时,支持更早干预。

关键数值与推荐

  • 2025年EASL指南扩大治疗资格,但未建议所有HBV DNA阳性个体治疗。
  • 指南按证据等级区分「应该治疗」与「可以治疗」,并列出可暂缓治疗的情形。

临床怎么用

  • 临床决策应基于HBeAg状态与HCC危险因素分层,而非仅凭HBV DNA阳性。
  • 对HBeAg阴性低风险者可随访观察,对HBeAg阳性高危者应积极考虑早期治疗。

局限性

  • 原文为节选,Tang等研究的具体样本量、效应值与随访细节未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In chronic hepatitis B virus (HBV) infection, the central debate remains whom and when to treat. The 2025 European Association for the Study of the Liver (EASL) Clinical Practice Guidelines (CPGs) 1 have expanded treatment eligibility but still do not suggest treatment for all HBV DNA-positive individuals. Instead, they reflect a nuanced, risk-based balance: reassuring that individuals with HBeAg-negative infection (formerly termed ‘inactive carriers’) generally have an excellent prognosis without treatment, while advocating earlier intervention in selected HBeAg-positive individuals, particularly when risk factors for hepatocellular carcinoma (HCC) are present. The guidelines distinguish between individuals who should or can be treated based on levels of evidence and outline situations where treatment may be deferred. 1 In this context, new data from Tang et al provide timely real-world validation of the EASL framework. 2 Analysing a large multicentre Chinese cohort, the authors show that HBeAg-negative infection with low...

来源:Gut (BMJ),查看原文。版权归原作者所有。

引用

  1. Gut (BMJ):Real-world evidence supports earlier treatment in HBeAg-positive but not HBeAg-negative chronic hepatitis B virus infection

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。